Century Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Century Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-122,112	Closed	-$19.1M	–	169
2014 Q3	$19.1M	Sell	122,112 -110,893	-48%	-$16.1M	1.13%	31
2014 Q2	$28.7M	Sell	233,005 -132,972	-36%	-$14.7M	1.52%	20
2014 Q1	$37.9M	Sell	365,977 -73,799	-17%	-$7.56M	1.77%	10
2013 Q4	$39.6M	Buy	439,776 +27,445	+7%	+$2.19M	1.58%	11
2013 Q3	$27.6M	Buy	412,331 +82,243	+25%	+$5.67M	1.15%	28
2013 Q2	$21.8M	Buy	+330,088	New	+$18.9M	0.86%	33

Other funds holding SLXP

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Century Capital Management's SLXP Position: Q4 2014 in Review

Century Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q4 2014, closing a stake of 122,112 shares — an estimated $19.1M sold.

Century Capital Management first reported a position in SLXP in Q2 2013 and held it in 6 quarters. The position peaked at $39.6M in Q4 2013. 347 funds tracked by Wall St. Rank hold SLXP as of Q4 2014.

Century Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q4 2014 after selling out during the quarter.
Century Capital Management sold 122,112 SALIX PHARMACEUTICALS LTD DEL shares in Q4 2014, an estimated $19.1M.
Century Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 6 quarters.
Century Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $39.6M in Q4 2013.
347 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q4 2014.

Based on Century Capital Management's 13F filing for Q4 2014, filed 11 Feb 2015.